Inhibition of HTLV-III/LAV replication by foscarnet
- 15 November 1985
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 34 (22) , 4075-4079
- https://doi.org/10.1016/0006-2952(85)90392-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Intravenous Foscarnet for the Treatment of Severe Cytomegalovirus Infection in Allograft RecipientsScandinavian Journal of Infectious Diseases, 1985
- RIBAVIRIN SUPPRESSES REPLICATION OF LYMPHADENOPATHY-ASSOCIATED VIRUS IN CULTURES OF HUMAN ADULT T LYMPHOCYTESThe Lancet, 1984
- Human T-lymphotropic retroviruses in adult T-cell leukemia-lymphoma and acquired immune deficiency syndromeJournal of Clinical Immunology, 1984
- Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-IIIScience, 1984
- Frequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDSScience, 1984
- The relative merits and drawbacks of new nucleoside analogues with clinical potentialJournal of Antimicrobial Chemotherapy, 1984
- Phosphonoformate Inhibits Reverse TranscriptaseJournal of General Virology, 1979
- Reversible Effects on Cellular Metabolism and Proliferation by Trisodium PhosphonoformateAntimicrobial Agents and Chemotherapy, 1978
- Trisodium Phosphonoformate, a New Antiviral CompoundScience, 1978